Table 3.
Unadjusted Analysis of the Relationship Between ANGPTL4 and Metabolic Parameters in the Study Subjects
| Nondiabetic | Type‐2 Diabetic | |||
|---|---|---|---|---|
| R | P Value | r | P Value | |
| Number, n | 201 | 185 | ||
| Age, y | −0.001 | 0.99 | 0.071 | 0.34 |
| Body mass index, kg/m2 | 0.060 | 0.40 | 0.176 | 0.017 |
| Systolic blood pressure, mm Hg | 0.033 | 0.65 | 0.188 | 0.010 |
| Diastolic blood pressure, mm Hg | 0.071 | 0.32 | 0.054 | 0.47 |
| Plasma glucose, mmol/L | 0.084 | 0.24 | 0.108 | 0.15 |
| Homa‐B, % | −0.033 | 0.64 | 0.059 | 0.42 |
| Homa‐IR, % | −0.003 | 0.96 | 0.181 | 0.014 |
| Serum triglyceride, mg/dL | 0.024 | 0.74 | 0.153 | 0.037 |
| Total cholesterol, mmol/L | 0.094 | 0.19 | 0.101 | 0.17 |
| LDL‐c, mmol/L | 0.097 | 0.17 | 0.069 | 0.35 |
| HDL‐c, mmol/L | −0.07 | 0.34 | −0.176 | 0.017 |
Pancreatic β‐cell function and insulin resistance were computed by Homeostasis Model of Assessment (Homa‐B and HOMA‐IR; http://www.dtu.ox.ac.uk/homacalculator/), using fasting insulin and glucose in the subjects. ANGPTL4 indicates angiopoietin‐like protein 4; HDL‐c, high‐density lipoprotein cholesterol; LDL‐c, low‐density lipoprotein cholesterol.